Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: emte: since this wasn't litigation.............

Feb 04, 2009 07:04AM

Feb 04, 2009 08:43AM
1
Feb 04, 2009 08:57AM
1
Feb 04, 2009 05:16PM
2
Feb 04, 2009 05:30PM
1
Feb 04, 2009 05:55PM

The "Opposition" segment of the German Patent and Trademark site says..in part....

Appeals against decisions in opposition procedures can be lodged at the Federal Patent Court (Bundespatentgericht).

Even after expiry of the opposition period, a patent in force can be challenged by an action for the declaration of nullity brought before the Federal Patent Court."

If we are in the Federal Patent Court in Germany to me that is similar to the Federal Appeals Court here in the US...now do we want to call that a litigated situation or just something that could effect every license in Germany and maybe even more far-reaching without using the word....LITIGATION....

No matter what ones calls it or labels it it should have been made public and included at least in the Risk Factors section of the Q and K...not to mention that our BOD and Leadershp IMO had ot know of this risk factor and with no diclosure how do they qualify to buy shares...

Once again all this does is, at a minimum, cast doubt upon the company and what they are not telling us...that doubt will effect new buyers and even the actions of some longtimers.

Share
New Message
Please login to post a reply